Dianxing X. Sun

Zhongshanxi Street
Shijiazhuang, 050082, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Meox1 promotes hepatocellular carcinoma progression potentially via regulation of cell cycle and p21 expression.

Meox1 promotes hepatocellular carcinoma progression potentially via regulation of cell cycle and p21 expression.

Journal: Cell adhesion & migration

Published: April 20, 2026

Identification of flavonoid-based small molecule inhibitors with dual-targeting capability against RdRp and Mpro of SARS-CoV-2.

Identification of flavonoid-based small molecule inhibitors with dual-targeting capability against RdRp and Mpro of SARS-CoV-2.

Journal: Bioorganic & medicinal chemistry letters

Published: August 07, 2025

4EBP1 phosphorylation mediates TGF-β1-induced hepatic fibrosis and upregulates HIF-1α expression.

4EBP1 phosphorylation mediates TGF-β1-induced hepatic fibrosis and upregulates HIF-1α expression.

Journal: iScience

Published: June 13, 2025

Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma.

Autophagy-related long non-coding RNA MIR210HG plays a therapeutic role in hepatocellular carcinoma.

Journal: Discover oncology

Published: July 18, 2024

Mesoderm/mesenchyme homeobox l may promote tumor progression in human hepatocellular carcinoma.

Mesoderm/mesenchyme homeobox l may promote tumor progression in human hepatocellular carcinoma.

Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University

Published: July 04, 2023

Correction to: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.

Correction to: B7-H3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via JAK2/STAT3/Slug signaling pathway.

Journal: Cancer cell international

Published: October 29, 2021

Drug Repurposing: An Alternative Strategy to Treat COVID-19.

Drug Repurposing: An Alternative Strategy to Treat COVID-19.

Journal: Current pharmaceutical biotechnology

Published: March 04, 2021

Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury.

Clinical significance of small molecule metabolites in the blood of patients with different types of liver injury.

Journal: Scientific reports

Published: February 03, 2021

Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

Combination of CpG Oligodeoxynucleotide and Anti-4-1BB Antibody in the Treatment of Multiple Hepatocellular Carcinoma in Mice.

Journal: OncoTargets and therapy

Published: May 06, 2020

Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.

Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.

Journal: Virology journal

Published: December 12, 2019

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.

CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma.

Journal: OncoTargets and therapy

Published: June 13, 2019

Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines.

Construction of a replication-competent hepatitis B virus vector carrying secreted luciferase transgene and establishment of new hepatitis B virus replication and expression cell lines.

Journal: World journal of gastroenterology

Published: May 20, 2019

Showing 1-12 of 32

Last Updated: 09/26/2026